ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMGastos comerciales, generales y administrativos168.5 M170.1 M212.5 M182.6 M190.6 M755.8 MInvestigación y desarrollo133.8 M149 M134 M127.5 M139.5 M550 MBeneficio operativo357.7 M382.8 M364.5 M388.5 M356.7 M1.49 BTotal de ingresos no operativos38.8 M40.7 M43.9 M49.5 M87.3 M221.4 MGastos por intereses, netos de intereses capitalizados7.9 M6.1 M7.3 M3 M3.1 M19.5 MIngresos no operativos, una vez deducidos los gastos por intereses33.5 M38.9 M36.7 M40.4 M37 M153 MIngresos/gastos extraordinarios-2.6 M-4.3 M-100 K6.1 M47.2 M48.9 MBeneficio antes de impuestos396.5 M423.5 M408.4 M438 M444 M1.71 BParticipación en los beneficios——————Impuestos95.2 M101.3 M98.9 M99.3 M79.7 M379.2 MParticipación minoritaria——————Otros ingresos/gastos después de impuestos2.6 M-9.4 M-4.6 M100 K33.6 M19.7 MBeneficio neto antes de actividades interrumpidas301.3 M322.2 M309.5 M338.7 M364.3 M1.33 BOperaciones suspendidas——————Beneficio neto301.3 M322.2 M309.5 M338.7 M364.3 M1.33 BAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas301.3 M322.2 M309.5 M338.7 M364.3 M1.33 BBeneficio básico por acción6.737.186.867.738.3630.13Beneficio por acción diluido6.236.636.417.167.6627.86Número medio de acciones ordinarias45.2 M44.9 M45.1 M43.8 M44.3 M178.1 MAcciones diluidas48.5 M48.6 M48.3 M47.3 M47.9 M192.1 MEBITDA377.4 M402.6 M385.6 M410.4 M379.5 M1.58 BEBIT357.7 M382.8 M364.5 M388.5 M356.7 M1.49 BCosto de los ingresos75.9 M92.5 M87.6 M100.9 M103.4 M384.4 MOtros costes de producción——————Amortización y depreciación (flujo de caja)19.7 M19.8 M21.1 M21.9 M22.8 M85.6 M
United Therapeutics Corporation - Common Stock
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.